[HTML][HTML] IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection

SA Younes, ML Freeman, JC Mudd… - The Journal of …, 2016 - Am Soc Clin Investig
SA Younes, ML Freeman, JC Mudd, CL Shive, A Reynaldi, S Panigrahi, JD Estes
The Journal of clinical investigation, 2016Am Soc Clin Investig
In HIV-1–infected patients, increased numbers of circulating CD8+ T cells are linked to
increased risk of morbidity and mortality. Here, we identified a bystander mechanism that
promotes CD8 T cell activation and expansion in untreated HIV-1–infected patients.
Compared with healthy controls, untreated HIV-1–infected patients have an increased
population of proliferating, granzyme B+, CD8+ T cells in circulation. Vβ expression and
deep sequencing of CDR3 revealed that in untreated HIV-1 infection, cycling memory CD8 T …
In HIV-1–infected patients, increased numbers of circulating CD8+ T cells are linked to increased risk of morbidity and mortality. Here, we identified a bystander mechanism that promotes CD8 T cell activation and expansion in untreated HIV-1–infected patients. Compared with healthy controls, untreated HIV-1–infected patients have an increased population of proliferating, granzyme B+, CD8+ T cells in circulation. Vβ expression and deep sequencing of CDR3 revealed that in untreated HIV-1 infection, cycling memory CD8 T cells possess a broad T cell repertoire that reflects the repertoire of the resting population. This suggests that cycling is driven by bystander activation, rather than specific antigen exposure. Treatment of peripheral blood mononuclear cells with IL-15 induced a cycling, granzyme B+ phenotype in CD8+ T cells. Moreover, elevated IL-15 expression in the lymph nodes of untreated HIV-1–infected patients correlated with circulating CD8+ T cell counts and was normalized in these patients following antiretroviral therapy. Together, these results suggest that IL-15 drives bystander activation of CD8+ T cells, which predicts disease progression in untreated HIV-1–infected patients and suggests that elevated IL-15 may also drive CD8+ T cell expansion that is linked to increased morbidity and mortality in treated patients.
The Journal of Clinical Investigation